Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy

Arch Gynecol Obstet. 2003 Aug;268(3):219-21. doi: 10.1007/s00404-003-0502-0. Epub 2003 Jun 18.

Abstract

Case report: We present the case of a 25-year-old woman with treatment resistant hyperemesis gravidarum in the 15th week with a 13 kg loss of body weight. When the patient asked for termination of the pregnancy because of the unbearable symptoms, treatment with intravenous mirtazapine (Remergil) was started.

Results: Nausea and vomiting disappeared within hours, pregnancy termination was no longer desired. The patient was discharged two weeks later in good health and at 36 weeks gestation a cesarean section was performed. Post partum evaluation as well as 6-month post-partum revealed no dysmorphology or laboratory abnormalities in the children.

Publication types

  • Case Reports

MeSH terms

  • Abortion, Induced / psychology*
  • Adult
  • Antidepressive Agents, Tricyclic / administration & dosage*
  • Cesarean Section
  • Female
  • Humans
  • Hyperemesis Gravidarum / drug therapy*
  • Infusions, Intravenous
  • Mianserin / administration & dosage*
  • Mianserin / analogs & derivatives*
  • Mirtazapine
  • Pregnancy
  • Pregnancy Trimester, Second
  • Twins*

Substances

  • Antidepressive Agents, Tricyclic
  • Mianserin
  • Mirtazapine